GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Covetrus Inc (NAS:CVET) » Definitions » Net Income (Continuing Operations)

Covetrus (Covetrus) Net Income (Continuing Operations) : $-13 Mil (TTM As of Jun. 2022)


View and export this data going back to 2019. Start your Free Trial

What is Covetrus Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Covetrus's Net Income (Continuing Operations) for the three months ended in Jun. 2022 was $-4 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Jun. 2022 was $-13 Mil.


Covetrus Net Income (Continuing Operations) Historical Data

The historical data trend for Covetrus's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Covetrus Net Income (Continuing Operations) Chart

Covetrus Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Net Income (Continuing Operations)
Get a 7-Day Free Trial 92.00 107.00 -983.00 -17.00 -54.00

Covetrus Quarterly Data
Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
Net Income (Continuing Operations) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -31.00 -4.00 -3.00 -2.00 -4.00

Covetrus Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-13 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Covetrus  (NAS:CVET) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.


Covetrus Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of Covetrus's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.


Covetrus (Covetrus) Business Description

Industry
Traded in Other Exchanges
N/A
Address
7 Custom House Street, Portland, ME, USA, 04101
Covetrus Inc is an animal-health technology and services company dedicated to supporting the companion, equine, and large-animal veterinary markets. Its segments are North America, Europe and the Asia Pacific (APAC) and Emerging Markets. The company's services include supply chain services, software solutions, and prescription management.
Executives
Benjamin Wolin director C/O EVERYDAY HEALTH, INC., 345 HUDSON STREET, 16TH FLOOR, NEW YORK NY 10014
Edward Mcnamara director C/O COVETRUS, INC., 7 CUSTOM HOUSE STREET, PORTLAND ME 04101
Rebecca Ann Kidd officer: Head of Global Operations 7 CUSTOM HOUSE STREET, PORTLAND ME 04101
Matthew Malenfant officer: Chief Commercial Officer 7 CUSTOM HOUSE STREET, PORTLAND ME 04101
Andrew B. Coxhead officer: See Remarks C/O RR DONNELLEY, 111 SOUTH WACKER DRIVE, CHICAGO IL 60606
Dustin Finer officer: Chief People Officer 7 CUSTOM HOUSE STREET, PORTLAND ME 04101
Paul R. Fonteyne director C/O RESTORBIO, INC., 501 BOYLSTON STREET SUITE 6102, BOSTON MA 02116
Laura J Phillips officer: See Remarks 7 CUSTOM HOUSE STREET, PORTLAND ME 04101
Michael Ellis officer: See Remarks C/O HS SPINCO, INC., 135 DURYEA ROAD, MELVILLE NY 11747
Timothy Ludlow officer: See Remarks C/O COVETRUS, INC., 7 CUSTOM HOUSE STREET, PORTLAND ME 04101
Georgina Wraight officer: See Remarks C/O COVETRUS, INC., 7 CUSTOM HOUSE STREET, PORTLAND ME 04101
David Stuart Hinton officer: See Remarks C/O HS SPINCO, INC., 135 DURYEA ROAD, MELVILLE NY 11747
Providenti Anthony C. Jr. officer: See Remarks 3760 ROCKY MOUNTAIN AVENUE, LOVELAND CO 80538
Jamey S Seely officer: General Counsel and Secretary C/O GATES INDUSTRIAL CORPORATION PLC, 1144 FIFTEENTH STREET, SUITE 1400, DENVER CO 80202
Sandra E Peterson director 100 PARSONS POND DRIVE, FRANKLIN LAKES NJ 07417